恢刺法治疗急性腰扭伤的临床观察

目的观察恢刺法治疗急性腰扭伤的临床效果。方法 60例急性腰扭伤患者随机分为治疗组与对照组,对照组采取普通针刺治疗,治疗组采取恢刺法治疗,7 d为1个疗程。结果在治疗后3、7 d后,治疗组患者腰痛视觉模拟量表(VAS)评分、腰椎活动ROM评分和血清C反应蛋白均明显低于对照组(P <0.05),日常生活动作评分明显高于对照组(P <0.05),中医综合疗效评价显示治疗组患者总有效率为85.71%,明显高于对照组的72.41%(P <0.05)。结论恢刺法治疗急性腰扭伤疗效明显。     

复元活血汤对老年腰椎管狭窄症患者术后凝血功能及下肢深静脉血栓形成的影响

目的观察复元活血汤对老年腰椎管狭窄症患者术后凝血功能及下肢深静脉血栓形成的影响。方法将老年腰椎管狭窄症患者60例随机分为观察组与对照组各30例,对照组给予围手术期常规处理,观察组在对照组的基础上加用复元活血汤。结果两组患者治疗后凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)均较治疗前明显升高(P<0.05),观察组升高更为明显(P<0.05)。观察组患者治疗后FDP较治疗前明显降低(P<0.05)。与对照组相比,观察组患者治疗后FDP明显降低(P<0.05)。两组患者治疗后D-二聚体均较治疗前明显降低(P<0.05),观察组下降更为明显(P<0.05)。而下肢深静脉血栓形成的发生率,观察组显著低于对照组(P<0.05)。结论复元活血汤能够调节老年腰椎管狭窄症患者术后凝血功能,降低下肢深静脉血栓形成的发生。     

中医特色护理技术干预对腰椎间盘突出术后关节功能及生活质量的影响

目的:观察中医特色护理技术干预对腰椎间盘突出术后患者关节功能和生活质量的影响。方法:将86例腰椎间盘突出症术后患者随机分为2组,对照组43例给予常规护理干预,观察组43例在对照组的基础上联合中医特色护理技术进行干预;治疗2周后比较2组腰椎日本骨科协会(JOA)评分、疼痛视觉模拟评分法(VAS)评分以生活质量量表(QLQ-C30)评分。结果:治疗后,2组JOA评分较治疗前升高(P<0.05),疼痛VAS评分较治疗前降低(P<0.05),且观察组2项评分改善较对照组更显著(P<0.05)。干预后,观察组患者社会功能、躯体功能、心理功能、物质功能等各项QLQ-C30评分均明显高于对照组,差异均有统计学意义(P<0.05)。结论:中医特色护理技术干预能有效缓解腰椎间盘突出术后患者的疼痛,促进腰椎功能恢复,提高患者生活质量。     

三维平衡正脊手法配合针刺治疗神经根型颈椎病临床研究

目的:观察三维平衡正脊手法配合针刺治疗神经根型颈椎病(CSR)的临床疗效。方法:将90例CSR患者运用随机数字表法分观察组、对照1组、对照2组,每组各30例。由于治疗过程中三组均有病例脱落,最终观察组、对照1组、对照2组参与疗效评价者分别为28例、29例、28例。三组患者均口服双氯芬酸钠缓释片,在此基础上,观察组采用三维平衡正脊手法配合针刺治疗,针刺穴位选取颈夹脊、天柱、后溪、申脉、悬钟、手三里、少海;对照1组采用常规推拿手法配合针刺治疗,针刺选穴与操作手法同观察组;对照2组单纯采用针刺治疗,针刺选穴与操作手法同以上两组。三组患者均每日治疗1次,10次为1个疗程,共治疗3个疗程。比较三组患者颈肩部视觉模拟评分法(VAS)评分、颈椎功能障碍指数(NDI)、颈椎病治疗成绩评分,评价临床疗效。结果:三组患者治疗后的VAS评分、NDI评分、颈椎病治疗成绩评分较治疗前均改善,差异有统计学意义(P<0.05)。三组患者治疗后的颈肩部VAS评分比较,差异有统计学意义(P=0.001);观察组治疗后的颈肩部VAS评分低于对照1组(P<0.001)和对照2组(P=0.042)。三组患者治疗后的NDI评分比较,差异有统计学意义(P<0.001);观察组治疗后的NDI评分低于对照1组和对照2组(P=0.036,P<0.001);对照1组治疗后的NDI评分低于对照2组(P=0.010)。三组患者治疗后的颈椎病治疗成绩评分比较,差异有统计学意义(P=0.002);观察组治疗后的颈椎病治疗成绩评分高于对照1组和对照2组(P=0.047,P<0.001)。观察组痊愈率、显效率均明显高于对照1组和对照2组,差异有统计学意义(P<0.05)。结论:三维平衡正脊手法配合针刺治疗CSR能有效缓解患者疼痛症状,改善患者NDI,临床疗效优于常规推拿手法结合针刺治疗及单纯针刺治疗。     

展筋和血饮对腰椎后路椎体间融合术后患者疼痛及炎症因子的影响

目的:观察展筋和血饮对腰椎后路椎体间融合术术后疼痛、炎症因子的影响。方法:将60例腰椎后路椎体间融合术后患者按照随机数字表法分为对照组和治疗组,对照组给予抗感染、改善循环及腰椎功能康复锻炼治疗,治疗组在对照组基础上联合口服展筋和血饮治疗。比较两组视觉模拟评分法(VAS)评分及白细胞计数、中性粒细胞比率和C反应蛋白水平。结果:治疗7 d后,治疗组总有效率93.33%高于对照组的73.33%,差异有统计学意义(P<0.05)。治疗4、7 d后,两组VAS评分、白细胞计数、中性粒细胞比率和C反应蛋白较治疗前改善; 治疗4 d后,治疗组VAS评分、中性粒细胞比率、C反应蛋白水平低于对照组,差异有统计学意义(均P<0.05); 治疗7 d后,治疗组VAS评分、白细胞计数、中性粒细胞比率、C反应蛋白水平低于对照组,差异有统计学意义(均P<0.05)。结论:展筋和血饮有助于减轻腰椎后路椎体间融合术术后疼痛,抑制炎症反应,改善患者生活质量。     

升清降浊法结合胸椎松动术治疗颈性眩晕60例

目的:观察升清降浊法结合胸椎松动术治疗颈性眩晕的临床疗效。方法:60例用升清降浊法结合胸椎松动术治疗。结果:痊愈18例,显效30例,有效8例,无效4例,总有效率93.3%。结论:升清降浊法结合胸椎松动术治疗颈性眩晕疗效较好。     

刺腰夹脊联合四指推脊柱调整手法对腰椎间盘突出症患者腰椎功能及疼痛程度的影响

目的:研究刺腰夹脊联合推拿(四指推脊柱调整手法)对腰椎间盘突出症(LDH)患者腰椎功能及疼痛程度的影响。方法:将100例LDH患者纳入研究。将其遵循随机信封法等分成联合组及对照组。对照组实施腰椎牵引联合常规推拿治疗,联合组则实施针刺腰夹脊联合推拿(四指推脊柱调整手法)治疗。评价两组疗效,治疗前后疼痛程度,治疗前后腰椎功能,治疗前后血清炎症因子水平。结果:联合组治疗总有效率优于对照组(P<0.05)。治疗后联合组及对照组的PRI评分均低于治疗前,且联合组低于对照组(均P<0.05)。治疗后联合组腰椎最大活动度及肌力正常百分比均高于对照组(均P<0.05)。治疗后联合组血清白细胞介素-1(IL-1)、白细胞介素-6(IL-6)及肿瘤坏死因子-α(TNF-α)水平均低于对照组(均P<0.05)。结论:针刺腰夹脊联合推拿(四指推脊柱调整手法)可显著改善LDH患者腰椎功能,同时可减轻患者疼痛,缓解炎症反应,值得临床应用。     

脊柱定点旋转复位手法治疗对613例腰椎间盘突出症患者腰椎活动度及活动度对称性的影响

目的:观察脊柱定点旋转复位手法治疗对腰椎间盘突出症(LDH)患者腰椎活动度及活动度对称性的疗效。方法:选择被诊断为LDH的住院患者613例,给予脊柱定点旋转复位法为主的手法治疗,2次/周,共3周,分别在治疗前及1个疗程后观察LDH患者疼痛VAS评分,腰椎屈曲、背伸、左右侧旋、左右侧屈活动度以及左右侧屈和左右侧旋两侧对称性的变化。结果:手法治疗后,LDH患者的VAS评分显著下降(P<0.01),腰椎6个方向的活动度均显著改善(P<0.01),两侧侧屈和侧旋运动的关节活动度的对称性显著增加(P<0.01)。结论:腰椎的关节活动度以及两侧运动的对称性可作为评价脊柱手法疗效评价的客观量化指标。脊柱定点旋转复位法改善了腰椎关节的灵活性以及运动时的左右对称性,可促进脊柱力学平衡的恢复。     

Postsynaptic distribution of IRSp53 in spiny excitatory and inhibitory neurons

The 53 kDa insulin receptor substrate protein (IRSp53) is highly enriched in the brain. Despite evidence that links mutations of IRSp53 with autism and other neuropsychiatric problems, the functional significance of this protein remains unclear. We used light and electron microscopic immunohistochemistry to demonstrate that IRSp53 is expressed throughout the adult rat brain. Labeling concentrated selectively in dendritic spines, where it was associated with the postsynaptic density (PSD). Surprisingly, its organization within the PSD of spiny excitatory neurons of neocortex and hippocampus differed from that within spiny inhibitory neurons of neostriatum and cerebellar cortex. The present data support previous suggestions that IRSp53 is involved in postsynaptic signaling, while hinting that its signaling role may differ in different types of neurons. J. Comp. Neurol. 522:2164–2178, 2014. © 2013 Wiley Periodicals, Inc.     

Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model

Alzheimer's disease (AD) is a complex and slowly progressing dementing disorder that results in neuronal and synaptic loss, deposition in brain of aberrantly folded proteins, and impairment of spatial and episodic memory. Most studies of mouse models of AD have employed analyses of cognitive status and assessment of amyloid burden, gliosis, and molecular pathology during disease progression. Here we sought to understand the behavioral, cellular, ultrastructural, and molecular changes that occur at a pathological stage equivalent to the early stages of human AD. We studied the TgCRND8 mouse, a model of aggressive AD amyloidosis, at an early stage of plaque pathology (3 months of age) in comparison to their wildtype littermates and assessed changes in cognition, neuron and spine structure, and expression of synaptic glutamate receptor proteins. We found that, at this age, TgCRND8 mice display substantial plaque deposition in the neocortex and hippocampus and impairment on cued and contextual memory tasks. Of particular interest, we also observed a significant decrease in the number of neurons in the hippocampus. Furthermore, analysis of CA1 neurons revealed significant changes in apical and basal dendritic spine types, as well as altered expression of GluN1 and GluA2 receptors. This change in molecular architecture within the hippocampus may reflect a rising representation of inherently less stable thin spine populations, which can cause cognitive decline. These changes, taken together with toxic insults from amyloid‐β protein, may underlie the observed neuronal loss. J. Comp. Neurol. 522:2319–2335, 2014. © 2014 Wiley Periodicals, Inc.